Want to see YB full AI Analyst Report?
YB Stock Chart & Stats
$13.83
-$0.11(-0.82%)
At close: 4:00 PM EDT
$13.83
-$0.11(-0.82%)
Day’s Range― - ―
52-Week Range$11.55 - $24.40
Previous Close$13.32
Volume25.17K
Average Volume (3M)38.73K
Market Cap
$563.79M
Enterprise Value-$25.86M
Total Cash (Recent Filing)$4.67B
Total Debt (Recent Filing)$4.25M
Price to Earnings (P/E)0.5
Beta0.72
Next Earnings
Dec 09, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield10.29%
Share Statistics
EPS (TTM)306.72
Shares Outstanding32,391,453
10 Day Avg. Volume45,901
30 Day Avg. Volume38,728
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)1.53
Price to Sales (P/S)1.17
P/FCF Ratio3.46
Enterprise Value/Market Cap-0.05
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda-0.02
Forecast
1Y Price Target
$15.50Price Target Upside12.08% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)31.84
Revenue Forecast (FY)$5.69B
Bulls Say, Bears Say
Bulls Say
AI-driven MarketingAn AI-powered marketing engine that generates customer insights and precisely matches customers with products can improve conversion efficiency and lower acquisition costs, enhancing competitive advantage.
Market PositioningYuanbao's role as a leading online health insurance broker enables capture of rising consumer demand and expanding online distribution, supporting potential revenue growth.
Product StrategyConcentration on commercial and mid-tier health insurance, which have simpler terms and smaller premiums, aligns with supportive policy and suits online sales for faster penetration in underdeveloped segments.
Bears Say
Financial And Industry RiskVolatile financial performance combined with the risk of slower industry growth would increase downside exposure for investors and weaken the company's outlook.
Regulatory And AI Valuation RiskPotential regulatory tightening and the risk of de-rating for AI-related businesses could materially pressure the company's market valuation and investor sentiment.
Valuation OutlookAn analyst neutral rating suggests the stock may be considered fairly valued, implying limited upside potential for investors despite growth opportunities.
Yuanbao, Inc. Unsponsored ADR News
YB FAQ
What was Yuanbao, Inc. Unsponsored ADR’s price range in the past 12 months?
Yuanbao, Inc. Unsponsored ADR lowest stock price was $11.55 and its highest was $24.40 in the past 12 months.
What is Yuanbao, Inc. Unsponsored ADR’s market cap?
Yuanbao, Inc. Unsponsored ADR’s market cap is $563.79M.
When is Yuanbao, Inc. Unsponsored ADR’s upcoming earnings report date?
Yuanbao, Inc. Unsponsored ADR’s upcoming earnings report date is Dec 09, 2026 which is in 59 days.
How were Yuanbao, Inc. Unsponsored ADR’s earnings last quarter?
Yuanbao, Inc. Unsponsored ADR released its earnings results on Sep 10, 2026. The company reported $0.21 earnings per share for the quarter.
Is Yuanbao, Inc. Unsponsored ADR overvalued?
According to Wall Street analysts Yuanbao, Inc. Unsponsored ADR’s price is currently Undervalued.
Does Yuanbao, Inc. Unsponsored ADR pay dividends?
Yuanbao, Inc. Unsponsored ADR pays a Notavailable dividend of $1.26 which represents an annual dividend yield of 10.29%. See more information on Yuanbao, Inc. Unsponsored ADR dividends here
What is Yuanbao, Inc. Unsponsored ADR’s EPS estimate?
Yuanbao, Inc. Unsponsored ADR’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Yuanbao, Inc. Unsponsored ADR have?
Yuanbao, Inc. Unsponsored ADR has 32,391,453 shares outstanding.
What happened to Yuanbao, Inc. Unsponsored ADR’s price movement after its last earnings report?
Yuanbao, Inc. Unsponsored ADR reported an EPS of $0.21 in its last earnings report. Following the earnings report the stock price went up 1.488%.
Which hedge fund is a major shareholder of Yuanbao, Inc. Unsponsored ADR?
Currently, no hedge funds are holding shares in YB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Yuanbao, Inc. Unsponsored ADR Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$15.50 (12.08% Upside)
$15.50 (12.08% Upside)
Blogger Sentiment
Bullish
YB Sentiment 100%
Sector Average 64%
Sector Average 64%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.01%
12-Months-Change
Fundamentals
Return on Equity
43.50%
Trailing 12-Months
Asset Growth
61.83%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Yuanbao, Inc. Unsponsored ADR
Yuanbao Inc., operating through its subsidiaries, manages an online platform for insurance distribution and various related services throughout the People's Republic of China. The company offers a diverse portfolio of insurance policies, including medical, critical illness, and life coverage. Beyond its core insurance offerings, it also provides specialized system services, which encompass precise marketing strategies and advanced analytics capabilities. Yuanbao Inc. was founded in 2019 and maintains its corporate headquarters in Beijing, China.
YB Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was strongly positive overall. Yuanbao reported 30.1% revenue growth, 35.6% net income growth, expanding cash reserves, progress on shareholder returns, continued product innovation and measurable AI-driven claims improvements. The main challenges were higher operating expenses and tax expense, some dilution of customer-acquisition ROI from external traffic competition, limited disclosure on the new advertising business and the still-maturing nature and accuracy limitations of AI agents in complex insurance scenarios.View all YB earnings summariesYB Stock 12 Month Forecast
Average Price Target
$15.50
▲(12.08% Upside)
Technical Analysis
Ownership Overview
―
Insiders
<0.01% Mutual Funds
4.26% Other Institutional Investors
95.71% Public Companies and
Individual Investors











